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The literature lists several reports to the effect that the common wart is infectious (1, 2,
3,4). Ciuffo (5), Serra (6), Wile and Kingery (7), Kingery (8), Ullman (9), Templeton (10),
and Findlay (11) have demonstrated the filterability of the causative agent of verruca and
have listed incubation periods in humans ranging from about four weeks to twenty months.
Warts or papillomas of some other animals (cow (12, 13, 14), dog (15), and rabbit (16, 17))
have also been shown tO contain a filterable agent that can reproduce lesions comparable
to those that occur naturally. However, with the exception of Ullman's report (9) of his
success in producing a vaginal papilloma in a bitch by using as inoculum a human laryngeal
papilloma and the mention by Hhodes (18) (no reference given) of the successful transfer
of human wart material to a monkey's prepuce, no indication has been found that the virus
has been grown in a tissue other than the natural host. Serra was unable to infect laboratory
animals with human warts. Findlay (11) has said that human warts are not infective for
dogs, rabbits, rats, mice, or guinea pigs, and Beard and Kidd (20) have been unable to
show any immunological relationship between the scm of humans or cattle affected with, or
recently recovered from, warts and the virus of Shope's papilloma when tested in the
rabbit.
Brunschwig et at. (21), even by implanting bits of human warts in tbe ears of each of
eight rabbits, failed to produce warts in the overlying tissue during a period of fifty to
one hundred and twenty days. Fclsher (22) reported an unsuccessful attempt to grow the
virus in developing hens' eggs. It may be of interest, theref ore to consider a case of warts
experinenced by the author and the subsequent culturing of an agent from this material
in the chick embryo.
So far as can be recalled, the author never had any warts or verruca-like growths at any
time during childhood or adolescence, nor can he recall any in other members of his family.
Some time during 1945—46, the head of a safety match loosened as it was struck. When
it ignited, it stuck to the palmar surface of the second phalanx of the third digit of the
right hand. When the wound healed, a considerable elevation of tissue remained, and this
in time appeared to become calloused. For two or three years, this single lesion persisted,
and no other appeared. Some time during 1949, it was noticed that the burned area of the
author's finger had begun to thicken and take on the characteristics of a wart. During the
summer of 1950, a typical verrucal lesion developed on the fourth digit, on the medial aspect
of the articulation of the second and third pbalanges. Soon afterward, another developed
on the lateral aspect of the third digit between the second and third phalanges—an area
which often rubbed on the second wart. Somewhat later, a fourth wart developed on the
medial aspect of the fifth digit between the first and second phalanges. During the winter
of 1950—51, very little increase, if any, can be recalled in the number of warts, although
the size of those already present increased. During the spring and early summer of 1951,
considerable gardening and carpentry were done, and many warts developed on the right
hand. It was noticed that a small wart had developed near the base of the nail of the second
digit where a "hang nail" had occurred, and another wart formed at the skin margin under
the nail of the fourth digit where a wood splinter had lodged. Five warts developed on the
fifth digit where the skin was abraded while using grass clippers. One wart appeared on the
left hand.
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EXPERIMENTAL
A few warts are not particularly troublesome, but when each gross break in
the skin appears likely to result in a new wart (18 developed, Fig. 1), one is apt
to be vexed. Consequently, a dermatologist was consulted on July 10, 1951. He
made a diagnosis of verruca vulgaris and suggested removal of the primary wart
at the site of the original burn. This was done by electrocautery and currettage.
The wart was placed in a sterile bandage and taken to the laboratory where it
was transferred to a sterile glass tube and frozen.
FIG. 1. A view of right hand (photograph taken October 7, 1951) showing some of the
larger warts.
Isolation of Virus
On July 12, 1951, the wart was ground with sterile sand in a mortar until the
whole was reduced to a very fine powder. This was then suspended in 3—4 ml. of
nutrient broth and frozen. An aerobic agar culture was sterile. On July 13, the
tube was thawed, the contents resuspended, centrifuged, and 1 ml. removed to
a second tube. To this were added 10,000 u. of penicillin and 10 mgm. of dihy-
drostreptomycin HC1, each suspended in 0.1 ml. of physiological NaC1. This
mixture was then inoculated by a method previously described (23), in a dose
of 0.2 ml. on the CAM of each of five chick embryos ten days old. The original,
untreated suspension was also inoculated on the CAM of two other eggs, but no
record was made of the dose. Since none of the embryos died, two of the first
group of five were examined on the fourth postinoculation day. No lesions were
seen. At seven days postinoculation, one of the three remaining embryos in the
antibiotic-treated group was normal except for a barely perceptible cyst at each
inoculation site; one had an edematous pole with very slight clouding at thei n-
oculation points; and the pole of one had the rough appearance of sandpaper
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with definite but small cysts at the inoculation sites. Of the embryos inoculated
with untreated suspension, the CAM of one was very edematous, particularly
at the pole, and inoculation point cysts were present. The last embryo, which
probably got more inoculum than any of the preceding, had a great many hard,
whitish "pearls" over the pole (air sac end) of the CAM. This embryo was small
FIG. 2. Chorio-allantoic membrane of a control egg (see Table 1) showing lesions result-
ing from verruca virus.
and appeared thin. The liver was green, and the kidneys were more tawny than
usual. Aerobic agar cultures from each of the above embryos remained sterile
after forty-eight hours of incubation.
A second passage was made, using as inoculum one-half of the membrane
showing the most lesions in the primary passage. Five embryos were seeded on
the CAM. One died of trauma, one died on the second, two on the fourth, and
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one on the sixth postinoculation days. The fourth-day dead had lesions resem-
bling the growth of fowl pox virus. The pole of the CAM of the sixth-day dead
was thickly covered with white lesions the size of rice grains. No lesions on areas
other than the pole were seen.
FIG. 3. Streptomycin + verruca virus. Lesions are equal to the control
Four other embryos were inoculated in the allantoic sac with the same ma-
terial used above. One died on each of the fourth, fifth, and seventh postinocula-
tion days. All of these and the live embryo had CAM lesions, which were smaller
than the previous group and centered about the point where the CAM was
perforated. In general, the dead embryos of this group were more congested
than those of the preceding.
Histopathological examination of the lesions is planned. Gross observations
made at intervals following CAM inoculation suggest that the first reaction is
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the development of a cystic proliferation, usually in three or four days. Later,
these clear cysts become larger and more dense, so that in six or seven days, the
appearance is similar to that in figures 2 and 3. The color varies from creamy
white to a greenish tinge. Occasionally, when the entire pole of the egg has been
infected, the inner shell membrane has developed an appearance of parchment.
Some of the larger primary lesions have had necrotic centers.
Filtrability
A Boerner filtrate was prepared from the primary passage membrane. Two of
the four CAM-inoculated eggs died of non-specific causes (one and two days)
and two lived seven days. One was completely normal; the other was dwarfed
and tucked or curled. The CAM of this latter egg had slightly thickened, whitish
streaks along the course of the larger blood vessels. Subsequent inoculation of
this membrane indicated that no verruca virus was present.
A Berkefeld "V" filtrate was prepared from the ground suspension of a heavily
infected membrane and inoculated on the CAM of six embryos. Two were alive
on the sixth day, and both had well-developed lesions. A Boerner filtrate pre-
pared from the same membrane suspension gave no lesions in six days on any
of five embryos inoculated on the CAM.
Tissue Susceptibility
Because several embryos dying on the fourth and fifth postinoculation days
were very much congested, it was wondered whether the virus had invaded the
embryo. To provide a rather rough answer, allantoic fluid, liver, and CAM from
a fifth-day dead embryo were saved in separate tubes. The possibility of con-
tamination with "shed" virus from the CAM was not excluded. Liver suspension
inoculated on the CAM yielded only a few small but definite lesions; when in-
oculated into the allantoic sac, two embryos yielded no growth, and one had a
small lesion where the CAM was pierced. Allantoic fluid inoculated on the CAM
gave excellent growth. When inoculated into the allantoic sac, one rather large
primary pole lesion and several secondary lesions resulted. The CAM inoculated
on the CAM gave, as expected, excellent growth; inoculation into the allantoic
sac resulted in small lesions on the CAM at the point of puncture. One embryo
developed a fatal hemorrhage on the third day.
Immunity
Shope (24), M'Fadyean and Hobday (25), De Monbreun and Goodpasture
(15) and Magalhaes (12) all refer to the immunity produced in certain domestic
animals by infection with papillomatosis or warts. Though it is known that
human infections often disappear spontaneously, evidence of human immunity
is not so striking as is that in domestic animals. Findlay (11) claims to have
become immune after three separate inoculations of wart material, but his serum
was not virucidal until he became hyper-immune. Brain (26) was unable to
demonstrate the presence of antibodies in patients' sera, and he had no thera-
peutic success with injecting vaccines prepared from warts. Maderna (27, 28)
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has shown that complement-fixing antibodies can be demonstrated in the sera
of human wart cases and that a skin reaction like the Frei test can be demon-
strated. It was therefore of interest to test for neutralizing antibodies in the
author's serum. Serum was collected on October 5, 1951. A heavily infected
membrane was ground as finely as possible with sand in a mortar and about 7
ml. of broth added. After centrifugation, 10-fold dilutions to 10 were prepared.
For virus titration, one set of tubes was prepared in which a volume of a dilu-
tion was added to a volume of broth. For neutralization, a volume of a dilution
was added to a volume of serum. After the contents were mixed, the tubes were
incubated for forty-five minutes at 370 and inoculated in a dose of 0.2 ml. on
the CAM. The serum neutralized no virus. Very abundant lesions resulted in
TABLE I
Verruca vulgaris virus versus certain drugs
DRUG AMOUNT PER EGG EGG NO. RESULT
Streptomycin 7.5 mgm. 1—4 Good to excellent growth.
3.25 mgm. 1—3 Good to excellent growth.
Terramycin 3.25 mgm. 1 No lesions.
2—3 Two small lesions apparently resulting from
reaction to toxicity.
4 Toxic death.
1.625 mgm. 1—2 No lesions.
3—4 Very small lesions from toxicity (P)
Aureomycin* 2.0 mgm. 1—4 All died of toxicity.
1.0 mgm. 1—2 Died of toxicity.
3 One very small lesion.
4 Four definite small lesions.
Phenyl Mer- 0.1 ml. of 1/25000 1 No lesions.
curie Nitrate 2—4 Very small lesions.
0.1 ml. of 1/50000 1—3 Definite growth.
Control Virus alooe 1—4 Normal growth (Fig. 2).
* Precipitated when mixed with nutrient broth.
each dilution to 10. The 10 dilution produced only small, localized, yellow
lesions in three of four eggs. In the fourth egg, there was fairly heavy growth.
Several attempts were made to infect the author's left hand. None were suc-
cessful. By December, 1951, all of the warts had disappeared, and despite many
minor injuries to the hands subsequently, no warts have developed.
Drug Sensitivity
In the original inoculation, the embryos inoculated with antibiotic-treated
inoculum gave less growth than other eggs inoculated with untreated inoculum.
Admittedly, this may have been (and probably was) the result of dose, but at
the time it was thought that it might have been a result of antiviral action of
the antibiotic agents. Accordingly, some trial dilutions to determine the upper
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limits of safety were prepared for terramycin, aureomycin, and phenyl mercuric
nitrate. * Thompson and Osteen (30) had previously reported on the toxicity of
streptomycin. Inocula were prepared so that each 0.2 ml. would represent a final
1:2000 dilution of virus (the same suspension as that used in the neutralization
test) and a certain known weight or dilution of drug. The mixtures were in-
Fin. 4. Terramycin + verruca virus. Three minute lesions not resembling verruca growth
in the upper left portion of membrane.
cubated fifteen minutes at 37°C., and the last egg was inoculated about thirty
minutes later. The results are shown in Table I.
* Dr. F. It. Beaudette, in discussing n paper (29) by Atanasiu, offered the suggestion
that it might be of interest to include this drug in the test. The borate salt was not locally
obtainable.
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The table shows that streptomycin had no deleterious effect on the virus of
verruca vulgaris (Fig. 3). All of the other dnigs appear to have had some effect
in reducing the vigor with which the virus grew (Fig. 4, 5, 6). Since the solubility
of phenyl mercuric nitrate is about one part in 1250 parts of water (31), it is
Fro. 5. Aureomycin + verruca virus. Three lesions in the upper left portion of mem-
brane.
possible that more concentrated solutions than those used for the test might
have given complete inactivation of the virus.
DISCUSSION
In view of the fact that "wart vaccines" for cattle have been commercially
produced in this country by egg embryo culture for several years (32), it is sur-
prising that no report of the successful culture of human verruca virus in chicken
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embryos could be found. It is true that Koch's postulates have not been fulfilled
by the material here reported, but it seems unlikely that the embryo lesions were
produced by an agent other than that obtained from a human wart.
FIG. 6. Phenyl mercuric nitrate + verruea virus. Very small lesions present
SUMMARY
An agent was obtained from a human wart which caused massive prolifera-
tion and "pearl" formation when inoculated on the CAM of 10-day-old chick
embryos. Some virus was present in the liver and allantoic fluid of affected em-
bryos, but it was much more concentrated in the CAM. It was readily filterable
through a Berkefeld "V" candle but not at all through a Boerner filter pad. No
virus-neutralizing antibodies were demonstrated in the patient's serum. The
agent was somewhat susceptible to the action of terramycin, aureomycin, and
phenyl mercuric nitrate but not to streptomycin.
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